GlassScriptPhysician profile
Attef A Mikhail
NPI 1700868742
$28,509.22
in general payments reported to CMS, 2019-2025
32 companies · $6,214 in 2025
The $6,214 reported for 2025 was more than what 95% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,413 · 2021: $546 · 2022: $3,419 · 2023: $2,172 · 2024: $2,597 · 2025: $6,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,420 · Travel and Lodging: $2,563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,420.11 |
| Travel and Lodging | $2,563.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $7,617.67 | 2019 | |
| Boston Scientific Corporation | $6,510.58 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Ekosonic, General - Therapies |
| Instylla, INC. | $2,384.49 | 2021-2024 | Instylla Microcatheter, Instylla Delivery Kit |
| Stryker Corporation | $1,662.01 | 2019-2025 | Spinejack, Autoplex, Flowtriever Catheter, S |
| Medtronic USA, INC. | $1,617.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $1,534.74 | 2025 | Microthermx Microwave Ablation System |
| Medtronic, INC. | $1,340.42 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Galil Medical INC. | $1,160.38 | 2019 | |
| Penumbra, INC. | $713.43 | 2023-2025 | Indigo System, Ruby Coil |
| Inari Medical, INC. | $630.46 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Canon Medical Systems USA, INC. | $404.67 | 2019 | |
| Becton, Dickinson and Company | $403.59 | 2019 | |
| Sirtex Medical INC | $338.52 | 2022-2023 | Sir-Spheres Microspheres |
| Angiodynamics, INC. | $333.74 | 2019-2025 | Alphavac, Venacure 1470 Pro |
| Histosonics, INC. | $259.38 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Delcath Systems | $234.52 | 2024 | Hepzato Kit |
| Nevro Corp. | $183.37 | 2024 | Senza |
| Advanced Critical Devices, INC. | $167.45 | 2024-2025 | Vascular Products |
| Medtronic Vascular, INC. | $159.92 | 2019 | |
| Terumo Medical Corporation | $139.46 | 2025 | Azur Cx Detachable |
| Ekos Corporation | $138.56 | 2019 | |
| Telix Pharmaceuticals | $129.91 | 2024 | Illuccix |
| Cook Medical LLC | $123.34 | 2021 | |
| Davol INC. | $92.89 | 2019 | |
| Philips North America LLC | $86.38 | 2019 | |
| Bard Peripheral Vascular, INC. | $57.95 | 2024-2025 | |
| Amgen INC. | $15.70 | 2024 | Prolia, Evenity |
| Thrombolex, INC. | $15.25 | 2023-2024 | Bashir Endovascular Catheter |
| Tactile Systems Technology INC | $14.33 | 2023 | Entre Plus, Flexitouch Plus |
| Shockwave Medical, INC | $13.91 | 2025 | |
| Dova Pharmaceuticals | $13.49 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Attef Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.